Perspective Therapeutics, Inc. (CATX) delivered a return of -21.47% over the past year. Since CATX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Perspective Therapeutics, Inc. one year ago would be worth $7,853 today, representing a loss of $2,147.

Perspective Therapeutics, Inc. (CATX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CATX, the total return equals the price-only return.

No, Perspective Therapeutics, Inc. (CATX) underperformed the S&P 500 by 42.31 percentage points over the past year. CATX delivered a total return of -21.47%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed CATX by 42.31pp during this period.

Perspective Therapeutics, Inc. (CATX) experienced a maximum drawdown of -58.84% over the past year, declining from its peak on 2025-10-15 to its trough on 2025-12-02. The stock recovered to its prior peak by 2026-02-02. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Perspective Therapeutics, Inc. (CATX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -67.4% (-10.6% CAGR) — $10,000 would have grown to $3,261. Over 20 years: -92.2% total return (-12.0% CAGR) — $10,000 → $779. Over 30 years: -94.1% total return (-9.0% CAGR) — $10,000 → $588. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Perspective Therapeutics, Inc.'s best calendar year was 2009 with a total return of 206.9%. Its worst year was 2008 with a total return of -91.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 298.0 percentage points.